Freedom from government Control, Lingaraja Temple setting precedent for rest of India
- ENTERTAINMENT
- 09 Jan 2021
India's drugs regulator DCGI has approved Oxford-Serum Institute's Covishield and Bharat Biotech's Covaxin for restricted emergency-use. While experts are alarmed at the grant of regulatory approval of Covaxin in spite of the lack of efficacy data, Covishield attracts a distinct concern altogether. These concerns however are with every vaccine out there in the world. It doesn’t demote the importance of fight against COVID-19 that India has begun with two desi vaccines.
READ MOREModerna was the second company to release promising preliminary data on a COVID-19 vaccine after Pfizer, in collaboration with BioNTech, reported that its vaccine was more than 90 percent effective in early results. To add to the spices, U.K.-based pharmaceutical company AstraZeneca has developed a vaccine with the University of Oxford, that showed an average efficacy of 70% in preventing COVID-19, according to the company. Which among these fares better?
READ MOREA newborn’s health is the prime concern for the Parents, breast milk being the essential component for the well-being and growth of the child. In this article we wade through some myths and facts associated with the practice of Breastfeeding.
READ MOREWhile WHO speculates that almost 10% of the world population has already been infected with Covid-19, a groundbreaking interim report on a clinical trial conducted in the hospitals show that patients on Ayurvedic medication are resolving more symptoms than on conventional medicine. The answer to one of the most troubling Pandemic of the world may finally lie in the cultural root of every traditional household in the land of Bharat, Ayurveda.
READ MOREThousands of people in northwest China have been diagnosed with a highly-infectious bacterial disease caused by the bacterial genus, Brucella. Unlike coronavirus the discovery of this bacteria dates back to 1850s in Malta when a group of British medical officers serving on the island, after the Crimean War detected this rare disease in Maltese citizens. Today, as it stands, the bacteria has infected nearly 10000 people in China as confirmed by the Gansu Provincial CDC.Is this the next pandemic?
READ MOREAfter facing an uncharted hiccup in the Phase 3 studies of Covid-19 vaccine being developed by AstraZeneca and the University of Oxford and trials put on hold due to a suspected serious adverse reaction of a participant in the United Kingdom, the trials have now resumed. On the other hand, the development and subsequent success of India’s Covaxin in the animal trials might help to assuage the concerns of many.
READ MORE